Random

FDA

diversity in clinical trials, people in a line

The Side Effects of Inequality: How Lack of Diversity in Clinical Trials Affects Drug Effectiveness and Safety

Daphne Berryhill

Open Letter to the FDA: You’re Protecting the Wrong People

Su Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti

FDA Issues High Risk Warning for Transvaginal Mesh

FDA Issues High Risk Warning For Transvaginal Mesh

FDA Commissioner Wants Doctor Education on Opioid Prescribing

FDA Commissioner Wants Doctor Education on Opioid Prescribing

Drug Side Effects Reported to FDA Skyrocket

Drug Interactions/Side Effects

Drug Side Effects Reported To FDA Skyrocket

FDA Gives Singulair the Thumbs Down for OTC

FDA Gives Singulair the Thumbs Down for OTC

The Trouble With Sunscreen Chemicals

The Trouble With Sunscreen Chemicals

Alternatives to Statins

Quick Hits: Alternatives to Statins & More

Scott Gottlieb’s FDA Legacy

Scott Gottlieb’s FDA Legacy

What’s Next for the Fosamax Case in the Supreme Court?

What’s Next for the Fosamax Case in the Supreme Court?

Suzanne B. Robotti

Are Direct-To-Consumer Ads Portraying Drug Risks Effectively?

Are Direct-To-Consumer Ads Portraying Drug Risks Effectively?

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

FDA Issues Related to Healthcare News

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

FDA Issues Related to Healthcare News Quick Hits

Quick Hits: FDA Approval for New Antibiotic, ADHD Med & More

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Required Postmarketing Studies For New Drugs

Required Postmarketing Studies For New Drugs

Diabetes News FDA FDA Watch Issues Related to Healthcare News

FDA Issues Warning on Common Diabetes Drugs

The FDA Has It Wrong on Kratom: How the Herb is Helping People

FDA SIDE EFFECTS UPDATE: Zepbound for Obstructive Sleep Apnea, Ibrance And Blood Clots, Plus More

FDA SIDE EFFECTS UPDATE: Zepbound for Obstructive Sleep Apnea, Ibrance And Blood Clots, Plus More

FDA Advisory Committee: Weighing Risks and Benefits of Opana ER

Weighing Risks and Benefits of Opana ER

Suzanne B. Robotti

Why A Lack of FDA Oversight Can Be Hazardous To Your Skin

Lack of FDA Oversight on Dermatologic Devices is Hazardous

Load More